Form D · Pharmaceuticals
BIOMERICA INC
Irvine, CA · CIK 0000073290
Offering snapshot reported Feb 27, 2020 · SEC filing
- Reported sold
- $2M Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 26, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 27, 2020 | Initial | $2,000,001 | No comparison | 1 | SEC filing |
| Jun 12, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-361534
Source: Form D, filed Feb 27, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Allen Barberi | Director |
| Francis R. Cano | Director |
| Jane Emerson | Director |
| Zackary Irani | Director, Executive |
| Janet Moore | Director, Executive |
| Mark Sirgo | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
17571 Von Karman Avenue
Irvine, CA, 92614
Irvine, CA, 92614